AT MARKET ISSUANCE SALES AGREEMENTNovavax Inc • December 30th, 2016 • Biological products, (no disgnostic substances) • New York
Novavax, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co., a Delaware limited liability company (“FBR”), as follows:
